AI Article Synopsis
- The study investigates the hemodynamic effects of the iVAC2L mechanical circulatory support system in patients undergoing high-risk coronary procedures.
- The research found that 22 out of 27 patients experienced left ventricular unloading, particularly those with moderate/severe mitral regurgitation and acute coronary syndrome.
- Pulsatile MCS significantly reduced left ventricular pressure and improved cardiac output among "responders," highlighting its potential benefits for certain high-risk patients.
Article Abstract
Objectives: To describe hemodynamic effects of iVAC2L mechanical circulatory support (MCS).
Background: MCS is increasingly used in the context of high-risk percutaneous coronary intervention (PCI). The effect of the pulsatile iVAC2L MCS on left ventricular loading conditions and myocardial oxygen consumption (MVO) is unknown.
Methods: This prospective single-arm two-center study included 29 patients who underwent high-risk PCI with iVAC2L MCS using simultaneous invasive pulmonary pressure monitoring and left ventricular pressure-volume analysis. Hemodynamic recordings were performed during steady state conditions with MCS off and on before and after PCI. Pressure-volume variations were analyzed to denote responders and non-responders.
Results: The mean age was 74 (IQR: 70-81) years and the mean SYNTAX score was 31 ± 8.3. Left ventricular unloading with iVAC2L MCS was demonstrated in 22 out of 27 patients with complete PV studies. Patients with moderate or severe mitral regurgitation or presenting with acute coronary syndrome (ACS) had higher filling pressures and volumes and were most responsive to iVAC2L unloading (9/10 patients with moderate or severe MR and 11/11 patients with ACS). Pulsatile MCS activation reduced MAP (-4%), SBP (-9%), ESP (-11%), ESV (-15%) and EDV (-4%) among responders but not among non-responders. Responders experienced significant reductions in afterload (Ea: -19%) with increases in stroke volume (+11%) and cardiac output (+11%).
Conclusions: Pulsatile iVAC2L MCS in patients with advanced coronary artery disease at high to prohibitive operative risk resulted in LV unloading and reduced myocardial oxygen consumption particularly in patients with ACS or significant MR with higher filling pressures at baseline.
Clinical Trial Registration: NCT03200990.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.carrev.2022.03.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pulsatile Left Ventricular Assistance in High-Risk Percutaneous Coronary Interventions: Short-Term Outcomes.
J Clin Med
September 2024
Department of Cardiology, National Medical Institute of the Internal Affairs and Administration Ministry, 02-005 Warsaw, Poland.
To document the real-world experience with the use of pneumatic pulsatile mechanical circulatory support (MCS) with the PulseCath iVAC2L during high-risk percutaneous coronary interventions (HR-PCIs). : The use of MCS in HR-PCIs may reduce the rate of major adverse cardiovascular events (MACEs) at 90 days. The PulseCath iVAC2L is a short-term pulsatile transaortic left ventricular (LV) assist device that has been in use since 2014.
View Article and Find Full Text PDFEffect of Next Generation Pulsatile Mechanical Circulatory Support on Cardiac Mechanics: The PULSE Trial.
Cardiovasc Revasc Med
September 2022
Department of Cardiology, Thoraxcentrum, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address:
Article Synopsis
- The study investigates the hemodynamic effects of the iVAC2L mechanical circulatory support system in patients undergoing high-risk coronary procedures.
- The research found that 22 out of 27 patients experienced left ventricular unloading, particularly those with moderate/severe mitral regurgitation and acute coronary syndrome.
- Pulsatile MCS significantly reduced left ventricular pressure and improved cardiac output among "responders," highlighting its potential benefits for certain high-risk patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!